Trial NCT02715804

View at ClinicalTrials.gov 
Org. Study IDs: HALO-109-301
Secondary IDs: 2015-004068-13

Last trial update was posted on 2020-07-14

MeSH Interventions

Gemcitabine Paclitaxel

MeSH Conditions

Adenocarcinoma Carcinoma, Ductal Carcinoma, Pancreatic Ductal

Other Conditions

Pancreatic Ductal Carcinoma

Stopping Reasons

Sponsor decision

Limitations And Caveats

Due to the negative study outcome, development of PEGPH20 was terminated.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID